Details for New Drug Application (NDA): 220320
✉ Email this page to a colleague
The generic ingredient in ATONCY is atomoxetine hydrochloride. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the atomoxetine hydrochloride profile page.
Summary for 220320
| Tradename: | ATONCY |
| Applicant: | Map77 |
| Ingredient: | atomoxetine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 220320
| Mechanism of Action | Norepinephrine Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 220320
Suppliers and Packaging for NDA: 220320
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATONCY | atomoxetine hydrochloride | SOLUTION;ORAL | 220320 | NDA | Validus Pharmaceuticals LLC | 30698-456 | 30698-456-02 | 1 BOTTLE, GLASS in 1 CARTON (30698-456-02) / 100 mL in 1 BOTTLE, GLASS |
| ATONCY | atomoxetine hydrochloride | SOLUTION;ORAL | 220320 | NDA AUTHORIZED GENERIC | Advagen Pharma Ltd. | 72888-456 | 72888-456-01 | 1 BOTTLE, GLASS in 1 CARTON (72888-456-01) / 100 mL in 1 BOTTLE, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 4MG BASE/ML | ||||
| Approval Date: | Mar 20, 2026 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
